Wenjuan Jiang1 article listing Wenjuan Jiang in Nature Communications, indexed by Paperzzz from Crossref and OSF.PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial Nature Communications